Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes

NCT02152371

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Valley Endocrine, Fresno Fresno, California, United States
  • Mills-Peninsula Diabetes Research Insitute San Mateo, California, United States
  • University Clinical Investigators, Inc. Tustin, California, United States
  • Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States
View all 40 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

NCT00355849

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pomona, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Palm Beach, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States
View all 69 locations
View Trial Details
Completed

A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes

NCT00330473

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntington Beach, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pomona, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Port Richey, Florida, United States
View all 60 locations
View Trial Details
Completed

Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes

NCT00325364

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sacramento, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Ana, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
View all 43 locations
View Trial Details
Completed

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)

NCT02451137

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Investigational Site Number 840731 Birmingham, Alabama, United States
  • Investigational Site Number 840305 Birmingham, Alabama, United States
  • Investigational Site Number 840811 Birmingham, Alabama, United States
  • Investigational Site Number 840218 Gulf Shores, Alabama, United States
View all 427 locations
View Trial Details
Completed

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

NCT02303730

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +8 more
Locations
  • Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Department of Endocrinology and Metabolism, Shanghai Minhang Central Hospital Shanghai, Shanghai Municipality, China
  • Department of Endocrinology and Metabolism,Huadong Hospital Shanghai, Shanghai Municipality, China
  • Department of Endocrinology and Metabolism,Shanghai 6th People's Hospital Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions